SAGE-319

N/A

Report date: 2025/04/01 15:33:48
NME

Base Information

Drug NameSAGE-319
Drug Alias NameSAGE-319
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor modulators
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsNeurodevelopmental DisordersNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSage Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSage Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeurodevelopmental DisordersNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A